Understanding Neomec
Neomec 10 mg is a pharmaceutical-grade ivermectin formulation manufactured by Intas Pharmaceuticals. Ivermectin is a semisynthetic macrocyclic lactone compound belonging to the avermectin class of antiparasitic agents. This compound has gained significant attention in laboratory research for its broad-spectrum activity against various parasitic organisms and potential antiviral properties. Each tablet contains 10 mg of ivermectin in a standardised pharmaceutical formulation, providing researchers with a consistent and reliable research material. As a well-established compound in the pharmaceutical industry, ivermectin serves as an important reference standard for studies investigating parasitic diseases, viral infections, and related cellular mechanisms. The compound’s mechanism involves binding to glutamate-gated chloride channels in invertebrate nerve and muscle cells, leading to increased permeability and cellular disruption. Researchers studying Stroid UK Shop often evaluate ivermectin as a benchmark for comparing novel therapeutic candidates.
Laboratory Research Applications
Ivermectin research encompasses multiple scientific disciplines, from parasitology to virology and immunology. Investigators examine this compound’s effects on various cellular pathways, including autophagy, viral replication mechanisms, and immune system modulation. Recent research has explored ivermectin’s potential interactions with viral proteins and its ability to inhibit nuclear transport processes in cell culture systems. Studies often investigate the compound’s activity against both RNA and DNA viruses in controlled laboratory environments. Researchers working with antiviral drug candidates frequently include ivermectin in comparative analyses to evaluate relative efficacy and mechanisms of action. The compound’s well-documented pharmacological profile makes it valuable for establishing baseline parameters in experimental protocols. Additionally, ivermectin serves as a positive control in many parasitological studies, particularly those investigating novel antiparasitic compounds. Research teams studying drug resistance mechanisms often analyse ivermectin-resistant cell lines to understand molecular adaptations. Investigators at facilities studying selective receptor modulators and bioactive peptides may also incorporate ivermectin studies as comparative controls.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active ingredient | Ivermectin |
| Strength per tablet | 10 mg |
| Manufacturer | Intas Pharmaceuticals |
| CAS Number | 70288-86-7 |
| Molecular formula | C₄₈H₇₄O₁₄ |
| Molecular weight | 875.09 g/mol |
| Storage conditions | Room temperature, dry environment |
| Product form | Oral tablets |
Research Compliance Statement
Neomec 10 mg tablets are supplied exclusively for in-vitro laboratory research and analytical applications. This product is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must ensure compliance with all applicable laboratory safety protocols and institutional guidelines when handling this material. The compound should be used only by qualified personnel in appropriate research facilities equipped with proper safety measures. All experimental work must be conducted in accordance with established research ethics and local regulations governing laboratory research compounds. Storage and disposal must follow institutional hazardous material procedures and environmental safety guidelines.
